Strictures, diaphragms, erosions or ulcerations of ischemic type in the colon should always prompt consideration of nonsteroidal anti-inflammatory drug-induced lesions

World Journal of Gastroenterology

Volumn 11, Issue 37, 2005, Pages 5828-5833

  Stolte, Manfred ^a   Karimi, Diana ^a   Vieth, Michael ^a   Volkholz, Hildegard ^a   Dirschmid, Klaus ^a   Rappel, Sigrid ^a   Bethke, Birgit ^a  

^a INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

ASA; Diaphragm; Erosion; Ischemic necrose; NSAIDs; Stricture; Ulceration

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; IBUPROFEN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PIROXICAM;

ADULT; AGE DISTRIBUTION; ARTICLE; COLON BIOPSY; COLON HEMORRHAGE; COLON ISCHEMIA; COLON OBSTRUCTION; COLON ULCER; COLONOSCOPY; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG INDICATION; DRUG INDUCED DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISCHEMIC COLITIS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PAIN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLYARTHRITIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; SEX RATIO; STOMACH EROSION; STOMACH ULCER; TRANSVERSE COLON; VALIDATION PROCESS;

EID: 27944476872     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i37.5828     Document Type: Article

References (62)

1. Lennert KA, Kootz F. Nil nocere. Arzneimittelbedingte Dünndarmulcera. Münch Med Wochenschr 1967; 40: 2058-2062
2. Sturges HF, Krone CL. Ulcerations and stricture of the jejunum in a patient of long-term indomethacin therapy. Am J Gastroenterol 1973; 59: 162-169
3. Huber T, Ruchti C, Halter F. Non-steroidal anti-inflammatory drug-induced colonic structures: a case report. Gastroenterology 1991; 100: 1119-1122
4. Fellows IW, Clarke JM, Roberts PF. Non-steroidal anti-inflammatory drug-induced jejunal and colonic diaphragm disease: a report of two cases. Gut 1992; 33: 1424-1426
5. Lanas A, Bajador E, Serrano P, Fuentes J, Carreno S, Guardia J, Sanz M, Montoro M, Sainz R. Nitrovasodilators, low-dose aspirin, other nonsteroidal anti-inflammatory drugs, and the risk upper gastrointestinal bleeding. N Engl J Med 2000; 343: 834-839
6. Rockall TA, Logan RF, Devlin HB. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the united kingdom. Steering committee and members of the national audit of acute upper gastrointestinal haemorrhage. BMJ 1995; 311: 222-226
7. Bjarnason I, Hayllar H, MacPherson AJ, Russell AS. Side effects of non steroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993; 104: 1832-1847
8. Langman MJS, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J 1985; 290: 347-349
9. Allison MC, Howatson AG, Torrance CJ, Lee FK, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992; 327: 749-754
10. Lanas A, Sekar MC, Hirschowitz BI. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992; 103: 862-869
11. Lanas A, Serrano P, Bajador E, Esteva F, Benito R, Sainz R. Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology 1997; 112: 683-689
12. Wilcox CM, Alexander LN, Cotsonis GA, Clark WS. Nonsteroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding. Dig Dis Sci 1997; 42: 990-997
13. Holt S, Rigoglioso V, Sidhu M, Irshad M, Howden CW, Mainero M. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal bleeding. Dig Dis Sci 1993; 38: 1619-1623
14. Wilson RG, Smith AN, Macintyre IMC. Complications of diverticular disease and non-steroidal anti-inflammatory drugs: a prospective study. Br J Surg 1990; 77: 1103-1104
15. Campbell K, Steele RJC. Non-steroidal anti-inflammatory drugs and complicated diverticular disease: a case-control study. Br J Surg 1991; 78: 190-191
16. Aldoori WH, Giovannucci EL, Rimm EB, Wing AL, Willett WC. Use of acetaminophen and nonsteroidal anti-inflammatory diverticular disease in men. Arch Fam Med 1998; 7: 255-260
17. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Bosi Ferraz M, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000; 343: 1520-1528
18. Robert A. An intestinal disease produced experimentally by a prostaglandin deficiency. Gastroenterology 1975; 69: 1045-1047
19. Whittle BJR. Temporal relationship between cyclo-oxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981; 80: 94-98
20. Evans SM, Whittle BJR. Interactive roles of superoxide and inducible nitric oxide synthase in rat intestinal injury provoked by non-steroidal anti-inflammatory drugs. Eur J Pharmacol 2001; 429: 287-296
21. Sigthorsson G, Simpson RJ, Walley M, Anthony A, Foster R, Hotz-Behoftsitz C, Palizbau A, Pombo J, Watts J, Morham SG, Bjarnason J. COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice. Gastroenterology 2002; 122: 1913-1923
22. De Vos M, Cuvelier C. Mielanths H. Ileocolonoscopy in seronegative spondylarthopathy. Gastroenterology 1989; 96: 339-344
23. Leirisolo-Repo H, Turunen U, Stenman S. High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum 1994; 37: 23-31
24. Smale S, Natt RS, Orchard TR, Russell AS, Bjarnason I. Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum 2001; 44: 2728-2736
25. Laine L, Connors LG, Reicin A, Howkey CJ, Burgos-Vargas R, Schnitzer TJ, Yu Q, Bombardier C. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology 2003; 124: 288-292
26. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin - like drugs. Nature 1971; 231: 232-235
27. Mahmud T, Rafi SS, Scott DL, Wrigglesworth JM, Bjarnason I. Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation. Arthritis Rheum 1996; 39: 1998-2003
28. Brune K, Schweitzer A, Eckert A. Parietal cells of the stomach trap salicylates during absorption. Biochem Pharmacol 1977; 26: 1735-1740
29. Lichtenberger LM, Wang ZM, Romero JJ, Ulloa C, Perez JC, Giraud MN, Barreto JC. Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nat Med 1995; 1: 154-158
30. Giraud MN, Motta C, Romero JJ, Lichtenberger LM. Interaction of indomethacin and naproxen with gastric surface-active phospholipids: a possible mechanism from the gastric toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs). Biochem Pharmacol 1999; 57: 247-254
31. Rampton DS. Non-steroidal antiinflammatory drugs and the lower gastrointestinal tract. Scand J Gastroenterol 1987; 22: 1-4
32. Pihan GRC, Szabo S. Vascular injury in acute gastric mucosa damage. Mediatory role of leucotrienes. Dig Dis Sci 1988; 33: 625-632
33. Davies NM. Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine. Dis Colon Rectum 1995; 38: 1311-1321
34. Wallace JL, Arfors KE, McKnight GW. A monoclonal antibody against the CK 18 leucocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit. Gastroenterology 1991; 100: 878-883
35. Davies NM, Wallace JW. Nonsteroidal anti-inflammatory drug-induced gastrointestinal toxicity: New insights into an old problem. J Gastroenterol 1997; 32: 127-133
36. Appleyard CB, McCafferty DM, Tigley AW, Swain MG, Wallace JL. Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. Am J Physiol 1996; 270: G42-48
37. Rothlein R, Czajkowski M, Kishimoto TK. Intercellular adhesion molecule-1 in inflammatory response. Chem Immunol 1991; 50: 135-142
38. Whittle BJR. New dogmas or old? Gut 2003; 52: 1379-1381
39. Bjarnason I, Takeuchi K, Simpson R. NSAIDs: the emperor's new dogma? Gut 2003; 52: 1376-1378
40. Aabakken L, Osnes M. Non-steroidal anti-inflammatory drug-induced disease in the distal ileum and large bowel. Scand J Gastroenterol 1989; 163: 48-55
41. Gargot D, Chaussade S, d'Alteroche L. Non-steroidal anti-inflammatory drug-induced colonic strictures: two cases and literature review. Gastroenterology 1995; 90: 2035-2038
42. Gut A, Halter F, Ruchti C. Nonsteroidal antirheumatic drugs and acetylsalicylic acid: adverse affects distal to the duodenum. Schweiz Med Wochenschr 1996; 126: 616-625
43. Bjarnason I, Hayllar J, MacPherson AJ, Russel AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993; 104: 1832-1847
44. Gibson GR, Whitacre EB, Ricotti CA. Colitis induced by non-steroidal anti-inflammatory drugs. Report of four cases and review of the literature. Arch Intern Med 1992; 152: 625-632
45. Sacanella E, Munoz F, Cardellach F, Estruch R, Miro O, Urbano-Marquez A. Massive haemorrhage due to colitis secondary to nonsteroidal anti-inflammatory drugs. Postgrad Med J 1996; 72: 57-58
46. Sukumar L. Recurrent small bowel obstruction with piroxicam. Br J Surg 1987; 74: 186
47. Bjarnason I, Price AB, Zanelli G, Smethurst P, Burke M. Clinicopathological features of nonsteroidal anti-inflammatory drug induced small intestinal strictures. Gastroenterology 1988; 94: 1070-1074
48. Lang J, Price AB, Levi AJ, Burke M, Gumpel JM, Bjarnason I. Diaphragm disease: pathology of disease of small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol 1988; 41: 516-526
49. Levi S, de Lacey G, Price AB, Gumpel MJ, Levi AJ, Bjarnason I. "iaphragm-like" strictures of the small bowel in patients treated with non-steroidal anti-inflammatory drugs. Br J Radiol 1990; 63: 186-189
50. Withcomb DC, Martin SP, Trellis AR, Evans BA, Becich MJ. "Diaphragmlike" stricture and ulcer of the colon during diclofenac treatment. Arch Intern Med 1992; 152: 2341-2343
51. Halter F, Weber B, Huber T, Eigenmann F, Frey M, Ruchti C. Diaphragm disease of the ascending colon. Association with sustained-release diclofenac. J Clin Gastroenterol 1993; 61: 74-80
52. Anthony A, Dhillon AP, Sim R, Nygard G. Pounder RE, Wakefield AJ. Ulceration, fibrosis and diaphragm-like lesions in the caecum of rats treated with indomethacin. Aliment Pharmacol Ther 1994; 8: 417-424
53. Robinson MWT, Leach ICH. Nonsteroidal anti-inflammatory drug-induced colonic stricture. An unusual cause of large bowel obstruction and perforation. Dig Dis Sci 1995; 40: 315-319
54. Klee M, Vogel CU, Diehl HG, Stolte M. Das Diaphragma-Kolon - Eine schwerwiegende Nebenwirkung nichtsteroidaler Antirheumatika (NSAR). Leber Magen Darm 1998; 28: 137-141
55. Stolte M, Panayiotou S, Schmitz J. Can NSAID/ASA-induced erosions of the gastric mucosa be indentified at histology? Pathol Res Pract 1999; 195: 137-142
56. Vieth M, Müller H, Stolte M. Can the diagnosis of NSAID-induced or Hp-associated gastric ulceration be predicted from histology? J Gastroenterol 2002; 40: 783-788
57. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable cornary artery disease. Lancet 1990; 336: 827-830
58. The SALT Collaborative Group. Swedish Aspirin Low-Dose Trial /SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 1991; 338: 1345-1349
59. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994; 330: 1287-1294
60. Newman JR, Cooper MA. Lower gastroindestinal bleeding and ischemic colitis. Can J Gastroenterol 2002; 19: 597-600
61. MacDonald PH. Ischaemic colitis. Best Pract Res Clin Gastroenterol 2002; 16: 51-61
62. Singh G, Ramey DR. NSAID induced gastrointestinal complications: the ARAMIS perspective -1997. Arthritis, Rheumatism, and Aging Medical Information System. J Rheumatol 1998; 25: 8-16